Ligand validation:6S9J

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6S9J designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S9J_NAG_B_307	32%	70%	0.169	0.84	0.47	0.69	-	1	0	0	100%	1
6S9J_NAG_B_306	28%	71%	0.19	0.84	0.46	0.65	-	1	0	0	100%	1
6S9J_NAG_A_401	24%	70%	0.208	0.836	0.52	0.64	-	1	0	0	100%	1
2WFO_NAG_A_1241	69%	59%	0.084	0.898	0.72	0.83	-	-	0	0	100%	1
7QU1_NAG_C_302	66%	73%	0.113	0.917	0.34	0.68	-	1	0	0	100%	1
9GHI_NAG_B_501	19%	58%	0.162	0.756	0.7	0.9	-	-	2	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.